$GTCH "We believe these changes will significantly

$GTCH "We believe these changes will significantly increase the device’s performance, accuracy, and consistency we are required to meet during the FDA certification. We believe these changes will ensure the product's safety, accuracy, and reliability along with high quality and efficiency. This technology, assuming we receive FDA certification of which there is no guarantee, is planned to be marketed and sold for personal and clinics usage also targeting it for the telemedicine arena. Another aspect is the device’s planned Artificial Intelligence technology that will be offering advanced features like real-time health statistics, analytics, monitoring and real time, geographically proximity alert to assist with avoiding health risks. The modifications also are focus on human engineering aspect in order to ensure easier usability for the vitals measurements like finger’s position pointers and physical finger’s location structural design. We put extra emphasis on making the device easy for use, mainly intuitive. Vitals results can be crucial indicators to assist with early detection of illness and we are working to improve the device’s performance and capabilities as preparations efforts for FDA clearance. It is in our R&D culture to constantly improve our technology in efforts to bring it to the highest standards and regulations, particularly in the medicine domain when it can save lives." Said Danny Rittman GBT/Tokenize and the Company’s CTO.

https://www.marketwatch.com/press-release/gbt...ws_seemore

Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!